Pnina Fishman - CAN FITE CEO, Director

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>CAN</div>
Dr. Pnina Fishman serves as Chief Executive Officer and served on our Board of Directors since September 2005. She has also served as the Chief Executive Officer of OphthaliX from November 21, 2011 through December 31, 2012. Dr. Fishman is the scientific founder of CanFite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or coauthored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. and OphthaliX Inc
Age: 69  CEO Since 1994  Ph.D    
972 3 924 1114  http://www.canfite.com
Fishman holds a Ph.D. in Immunology from the Bar Ilan University in Ramat Gan, Israel.

Management Efficiency

The company has return on total asset (ROA) of (34.67) % which means that it has lost $34.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (125.2) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Found 2 records

CEO Since

Anat CohenDayagCOMPUGEN

Company Summary

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver and inflammatory disease, and sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. CAN FITE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 7 people.CAN FITE BIOPHARMA (CANF) is traded on Tel Aviv Stock Exchange in Israel and employs 7 people.


Motti Farbstein, CFO, COOView
Abraham Sartani, DirectorView
Guy Regev, DirectorView
Ilan Cohen, Chairman of the BoardView
Israel Shamay, External DirectorView
Pnina Fishman, CEO, DirectorView

Stock Performance Indicators

Did you try this?

Run Portfolio Optimization Now


Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

CAN FITE Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for PACCAR and Deere Company. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.